Search Page

1

Cite

Share

Pharmacologic treatment options for type 1 diabetes: what's new?

Nally LM, Sherr JL, Van Name MA, Patel AD, Tamborlane WV. Nally LM, et al. Among authors: van name ma. Expert Rev Clin Pharmacol. 2019 May;12(5):471-479. doi: 10.1080/17512433.2019.1597705. Expert Rev Clin Pharmacol. 2019. PMID: 30892094 Free PMC article. Review.

Cite

Share

2

Cite

Share

Benefits and Barriers of Continuous Glucose Monitoring in Young Children with Type 1 Diabetes.

Hilliard ME, Levy W, Anderson BJ, Whitehouse AL, Commissariat PV, Harrington KR, Laffel LM, Miller KM, Van Name M, Tamborlane WV, DeSalvo DJ, DiMeglio LA. Hilliard ME, et al. Among authors: van name m. Diabetes Technol Ther. 2019 Sep;21(9):493-498. doi: 10.1089/dia.2019.0142. Epub 2019 Jul 9. Diabetes Technol Ther. 2019. PMID: 31287721 Free PMC article.

Cite

Share

3

Cite

Share

Fructose Consumption Contributes to Hyperinsulinemia in Adolescents With Obesity Through a GLP-1-Mediated Mechanism.

Galderisi A, Giannini C, Van Name M, Caprio S. Galderisi A, et al. Among authors: van name m. J Clin Endocrinol Metab. 2019 Aug 1;104(8):3481-3490. doi: 10.1210/jc.2019-00161. J Clin Endocrinol Metab. 2019. PMID: 30938760 Free PMC article. Clinical Trial.

Cite

Share

4

Cite

Share

A Low ω-6 to ω-3 PUFA Ratio (n-6:n-3 PUFA) Diet to Treat Fatty Liver Disease in Obese Youth.

Van Name MA, Savoye M, Chick JM, Galuppo BT, Feldstein AE, Pierpont B, Johnson C, Shabanova V, Ekong U, Valentino PL, Kim G, Caprio S, Santoro N. Van Name MA, et al. J Nutr. 2020 Sep 1;150(9):2314-2321. doi: 10.1093/jn/nxaa183. J Nutr. 2020. PMID: 32652034 Free PMC article. Clinical Trial.

Cite

Share

5

Cite

Share

The present and future treatment of pediatric type 2 diabetes.

Van Name MA, Guandalini C, Steffen A, Patel A, Tamborlane W. Van Name MA, et al. Expert Rev Endocrinol Metab. 2018 Jul;13(4):207-212. doi: 10.1080/17446651.2018.1499467. Epub 2018 Jul 23. Expert Rev Endocrinol Metab. 2018. PMID: 30063424 Review.

Cite

Share

6

Cite

Share

The omentum of obese girls harbors small adipocytes and browning transcripts.

Tarabra E, Nouws J, Vash-Margita A, Nadzam GS, Goldberg R, Van Name M, Pierpont B, Knight JR, Shulman GI, Caprio S. Tarabra E, et al. Among authors: van name m. JCI Insight. 2020 Mar 26;5(6):e135448. doi: 10.1172/jci.insight.135448. JCI Insight. 2020. PMID: 32125283 Free PMC article.

Cite

Share

7

Cite

Share

Alcohol Use and Clinical Outcomes in Adults in the Type 1 Diabetes Exchange.

Alessi SM, Foster NC, Rash CJ, Van Name MA, Tamborlane WV, Cengiz E, Polsky S, Wagner J. Alessi SM, et al. Among authors: van name ma. Can J Diabetes. 2020 Aug;44(6):501-506. doi: 10.1016/j.jcjd.2020.06.005. Epub 2020 Jun 10. Can J Diabetes. 2020. PMID: 32792103

Cite

Share

8

Cite

Share

IMPACT OF SWITCHING YOUTH WITH DIABETES TO INSULIN DEGLUDEC IN CLINICAL PRACTICE.

Elahi S, Patel AD, Guandalini C, Steffen A, Sherr J, Tamborlane WV, Van Name MA. Elahi S, et al. Among authors: van name ma. Endocr Pract. 2019 Mar;25(3):226-229. doi: 10.4158/EP-2018-0417. Endocr Pract. 2019. PMID: 30913005

Cite

Share

9

Cite

Share

Transforming Performance of Clinical Trials in Pediatric Type 2 Diabetes: A Consortium Model.

Van Name M, Klingensmith G, Nelson B, Wintergerst K, Mitchell J, Norris K, Tamborlane WV; Pediatric Diabetes Consortium. Van Name M, et al. Diabetes Technol Ther. 2020 Apr;22(4):330-336. doi: 10.1089/dia.2019.0448. Diabetes Technol Ther. 2020. PMID: 31859529 Free PMC article.

Cite

Share

10

Cite

Share

Moving toward the ideal insulin for insulin pumps.

Cengiz E, Bode B, Van Name M, Tamborlane WV. Cengiz E, et al. Among authors: van name m. Expert Rev Med Devices. 2016;13(1):57-69. doi: 10.1586/17434440.2016.1109442. Epub 2015 Nov 11. Expert Rev Med Devices. 2016. PMID: 26560137 Review.

Cite

Share